
Pharma Pulse 9/6/24: Validating COAs, Simplified HIV Treatments Can Lead to Lower Healthcare Costs & more
With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.
HIV treatments using a single pill improve adherence and are cheaper to maintain.
State, federal and industry requirements aim to protect the U.S. from hackers but complicate compliance.
DermaSensor Inc. is proud to recognize The FSU Family Medicine Residency Program - BayCare Health System (Winter Haven) in becoming the country’s first Family Medicine Physician Residency Program to integrate DermaSensor into its curriculum. This innovative initiative underscores the program's commitment to providing comprehensive healthcare and enhancing the skills of future family medicine physicians.
We’re ready for November and beyond. VP of Manufacturer Operations and Data Services Gregg Gorniak highlighted our preparedness for the upcoming November 27 DSCSA deadline in a recent @PharmaCommerce article. #DSCSA #pharmacompliance
https://ow.ly/Hav150TeFEy
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

